Preparing Supply Chains for Brexit

03 May 2018

As if UK Modern Slavery Act (MSA) compliance and the Falsified Medicines Directive (FMD) were not enough, Brexit carries enough uncertainty to keep even the most intrepid supply chain executives up at night.


With the terms of a final trade deal still unclear it is easy to become paralysed by the lack of clarity on what the future trading environment in Europe will look like. However, there will be precious little time to enact meaningful change once this clarity is provided.

Johnathon Marshall and Chris Cartmell have written a piece for Pharmaceutical Exec Europe on the actions that can be taken now to reduce risk and prepare organisations to be agile in the face of this uncertainty. You can read the full article here.

Pharmaceutical Executive Europe is a print and digital magazine for the pharma industry, offering news and opinions, analysis, features and executive profiles:

Johnathon Marshall | Partner
Profile | Email | +44 (0)207 212 3392

Chris Cartmell | PwC Legal
Profile | Email | +44 (0)20 7212 8849




Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated and will not appear until the author has approved them.